JIASHAN COUNTY HUXI FINE CHEMICALS FTYBusiness Directories,Company Directories

Company Name: Corporate Name:	JIASHAN COUNTY HUXI FINE CHEMICALS FTY
Company Title:
Company Description:
Keywords to Search:
Company Address:	69 Youdian Road, Jiashan County, Zhejiang,,,China
ZIP Code: Postal Code:	314102
Telephone Number:	86-573-4564575
Fax Number:
Website:
Email:
Industrial Classification:	Household products -- Daily-Use Chemicals -- Cosmetic Products
Number of Employees:
Sales Amount:
Credit History: Credit Report:
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
WUHU HUAFU FINE CHEMICAL FTY
WUJIANG CITY LILI HUJIANG FINE CHEMICALS FACTORY
LAYLA COSMETIC

Next company profile:
BEIJING XINXING FINE CHEMICAL FTY
SUZHOU CITY SHENJIANG FINE CHEMICALS FTY
TIANJIN FINE CHEMICAL PLANT BRANCH NO. 2

Company News:

FDA requires updated warning about rare heart risk with COVID . . .
U S health officials have expanded warnings about a rare heart side effect associated with the two leading COVID-19 vaccines
FDA expands COVID vaccine warning about heart side effect . . .
The FDA is requiring COVID vaccine makers Pfizer and Moderna to update their warnings about the possible risk of myocarditis and pericarditis
FDA requires updated warning about rare heart risk with COVID . . .
FDA requires updated warning about rare heart risk with COVID shots U S health officials have expanded warnings about a rare heart side effect associated with the two leading COVID-19 vaccines
FDA Approves Required Updated Warning in Labeling of mRNA . . .
The Fact Sheets for Healthcare Providers and for Recipients and Caregivers for Moderna COVID-19 Vaccine and Pfizer-BioNTech COVID-19, which are authorized for emergency use in individuals 6 months
FDA warns of heart risk with Pfizer, Moderna COVID vaccines
The U S Food and Drug Administration (FDA) has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines The updated warnings highlight a rare risk of heart inflammation in
FDA Expands Heart Risk Warning for Pfizer and Moderna COVID . . .
Washington, D C — The U S Food and Drug Administration (FDA) is updating its safety labels for the Pfizer and Moderna COVID-19 vaccines to include expanded warnings about the risk of heart inflammation Both vaccines already carry warnings about myocarditis, a rare condition that causes inflammation of the heart muscle
FDA requires Covid vaccine makers to expand warning about . . .
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart
FDA finalizes myocarditis label updates for COVID vaccines
The FDA has approved required updates to the labeling of Pfizer’s Comirnaty and Moderna’s Spikevax COVID-19 vaccines to include revised warnings about the risk of myocarditis and pericarditis
FDA Requires Updated Warning About Rare Heart Risk With COVID . . .
The FDA said Wednesday it has expanded existing warnings on the two leading COVID-19 vaccines about a rare heart side effect mainly seen in young men Myocarditis, a type of heart inflammation
FDA requires updated warning about rare heart risk with COVID . . .
U S health officials have expanded warnings about a rare heart side effect associated with the two leading COVID-19 vaccines The Food and Drug Administration announced the update Wednesday,